Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C. M. Cramer-van der Welle"'
Autor:
R. K. Ismail, F. M. N. H. Schramel, M. van Dartel, A. M. G. Pasmooij, C. M. Cramer-van der Welle, D. L. Hilarius, A. de Boer, M. W. J. M. Wouters, E. M. W. van de Garde
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be on
Externí odkaz:
https://doaj.org/article/9bc02c75012f48ce8b31b16322dfce7b
Autor:
R. K. Ismail, F. M. N. H. Schramel, M. van Dartel, A. M. G. Pasmooij, C. M. Cramer-van der Welle, D. L. Hilarius, A. de Boer, M. W. J. M. Wouters, E. M. W. van de Garde
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/e72d4cd774214abea8c113ebbf872ac5
Autor:
M. V. Verschueren, C. M. Cramer - van der Welle, M. Tonn, F. M. N. H. Schramel, B. J. M. Peters, E. M. W. van de Garde
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Several observational studies suggested that gut microbiome-affecting-medication impairs the effectiveness of immunotherapy in patients with metastatic non-small-cell lung cancer (NSCLC). We postulated that if the effectiveness of immunother
Externí odkaz:
https://doaj.org/article/a0e194b7608d42b8959e5d8b5ea66396